ConductScience.org, home

Paper32504698

An initial screening strategy based on epidemiologic information in esophageal cancer screening: a prospective evaluation in a community-based cancer screening cohort in rural China.

Chen W and 21 others. Gastrointest Endosc, 2021. Cited by 15 papers, by iCite.

Cite this record

ConductScience Library. An initial screening strategy based on epidemiologic information in esophageal cancer screening: a prospective evaluation in a community-based cancer screening cohort in rural China. Papers, record 32504698. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32504698

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
An initial screening strategy based on epidemiologic information in esophageal cancer screening: a prospective evaluation in a community-based cancer screening cohort in rural China.
PubMed
Journal
Gastrointest Endosc
PubMed
Year
2021
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
15
iCite
Relative citation ratio, by iCite
0.78
iCite
Revised in PubMed
2021-05-31
PubMed

Authors22

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Chen WWanqing
2Li HHe
3Zheng RRongshou
4Ren JJiansong
5Shi JJufang
6Cao MMaomao
7Sun DDianqin
8Sun XXibin
9Cao XXiaoqin
10Zhou JJinyi
11Luo PPengfei
12Wang JJialin
13Ma HHengmin
14Shao TTiantang
15Zhao CChunling
16He SShilin
17Sun DDaokuan
18Xu YYuluan
19Wu PPengli
20Zeng HHongmei

Source PubMed

See all 22 authorsDownload CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Carcinoma, Squamous CellMajor topic
Esophageal NeoplasmsMajor topic
Esophageal Squamous Cell CarcinomaMajor topic
China
Early Detection of Cancer
Humans
Prospective Studies
Risk Factors

Source PubMed

Download CSV of topics

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in33353612The use of questionnaire-based risk-stratification tools in screening for esophageal squamous cell carcinoma.https://conductscience.org/library/papers/33353612

Source PubMed

Download CSV of comments and corrections

Cited by12

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.

PMIDTitleJournalYearIn PapersSource
42823403Global incidence of esophageal cancer by histological and anatomical subtypes.Nat Commun2026https://conductscience.org/library/papers/42823403PubMed
41654824Trend analysis of liver cancer mortality in Chinese residents from 2002 to 2021.BMC Cancer2026https://conductscience.org/library/papers/41654824PubMed
41408438Cohort profile: the National Early Gastrointestinal Cancer Cohort (NEGCC) study in China.Surg Endosc2026https://conductscience.org/library/papers/41408438PubMed
40647436Development and Validation of a Score-Based Model for Estimating Esophageal Squamous Cell Carcinoma and Precancerous Lesions Risk in an Opportunistic Screening Population.Cancers (Basel)2025https://conductscience.org/library/papers/40647436PubMed
38848004Improving esophageal cancer screening across the globe: Translating knowledge into action.Indian J Gastroenterol2024https://conductscience.org/library/papers/38848004PubMed
38544481Reducing the global cancer burden with gastrointestinal screening: China's 30 years practice.Cancer Biol Med2024https://conductscience.org/library/papers/38544481PubMed
37680952Long-term esophageal cancer risk and distinct surveillance intervals after a single endoscopy screening: a multicentre population-based cohort study.EClinicalMedicine2023https://conductscience.org/library/papers/37680952PubMed
36994213Clinical characteristics and changing trajectories of esophageal cancer and gastric cancer in China from 2010 to 2019: An analysis of a hospital-based database of 24,327 patients.Front Oncol2023https://conductscience.org/library/papers/36994213PubMed
36701154Development and Validation of Esophageal Squamous Cell Carcinoma Risk Prediction Models Based on an Endoscopic Screening Program.JAMA Netw Open2023https://conductscience.org/library/papers/36701154PubMed
36534402Long-term Incidence Rates of Esophageal Squamous Cell Carcinoma in Chinese Patients With Low-grade Intraepithelial Neoplasia and Association of Surveillance Endoscopy With Incidence.JAMA Netw Open2022https://conductscience.org/library/papers/36534402PubMed
34878149CtBP2 interacts with TGIF to promote the progression of esophageal squamous cell cancer through the Wnt/β‑catenin pathway.Oncol Rep2022https://conductscience.org/library/papers/34878149PubMed
34527592Development and Validation of an Esophageal Squamous Cell Carcinoma Risk Prediction Model for Rural Chinese: Multicenter Cohort Study.Front Oncol2021https://conductscience.org/library/papers/34527592PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/32504698

GET https://conductscience.org/api/papers/v1/32504698/authors?page=2